Source: International Congress 2016 – China Session II



Rating:

Share or cite this content

Citations should be made in the following way:
Giovanni Battista Migliori (Varese, Italy). New perspectives in MDR-TB management. International Congress 2016 – China Session II

Member's Comments

No comment yet.

Related content which might interest you: New guidelines to manage MDR-TB Source: School Course 13 Year: 2013 New methodologogic approaches to the management of antituberculous service Source: Eur Respir J 2003; 22: Suppl. 45, 381s Year: 2003 Management of drug resistant pulmonary TB. New problems and perspectives Source: Annual Congress 2009 - Multi/extensively-drug resistant tuberculosis Year: 2009 New perspectives in PGD prevention and treatment Source: School Course 2012 - Lung Transplantation Year: 2012 MDR-TB guidelines: what is new on clinical management Source: ERS Webinar 2020: MDR-TB guidelines: what is new on clinical management Year: 2020 New frontiers in the management of asthma Source: International Congress 2017 – State of the art session: "Paediatric" Year: 2017 New approaches to treatment of HIV-associated tuberculosis in penitentiary institutions of Belarus Source: Eur Respir J 2004; 24: Suppl. 48, 651s Year: 2004 New experiences from global use of new tools in TB management and control Source: Annual Congress 2013 –PG7 Tuberculosis: innovations in clinical and public health management Year: 2013 MDR-TB management: what is new? Source: School Course 2012 - TB and M/XDR-TB: from clinical management to control and elimination Year: 2012 The health economics of treating MDR-TB in the Indian private sector Source: International Congress 2016 – How the increasing complexity of chronic care management challenges ethics and costs in our healthcare system Year: 2016 New and repurposed drugs for MDR-TB patients Source: International Congress 2017 – PG2 Multidrug-resistant tuberculosis management in settings with a low tuberculosis incidence  Year: 2017 Problems and perspectives of microbiology diagnosis of TB in Russia Source: Eur Respir J 2002; 20: Suppl. 38, 169s Year: 2002 Enhancing patient safety: New WHO guidance on pharmacovigilance in tuberculosis care Source: Annual Congress 2012 - Tuberculosis: epidemiological and public health features Year: 2012 New and repurposed TB drugs use in children and adolescents with M/XDR-TB Source: International Congress 2017 – Treatment of multi-drug-resistant tuberculosis (MDRTB): where are we now? Year: 2017 National evidence on the inefficiency of an inpatient model of tuberculosis management in Eastern Europe Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection in subpopulations Year: 2013 New approaches to MDR/XDR TB chemotherapy in children and adolescents Source: International Congress 2019 – Tuberculosis: treatment and management Year: 2019 Impact of social support programme on MDR-TB patients' treatment outcomes Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 3 Year: 2014 A review of the management of MDR-TB in a resource-limited setting in India Source: Annual Congress 2010 - Global tuberculosis control Year: 2010 MDR-TB in Eastern Europe: new public health interventions Source: International Congress 2016 – The problem of multidrug-resistant tuberculosis Year: 2016 XDR-TB: Indian perspective Source: Eur Respir J 2007; 30: 178-179 Year: 2007